Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive.
Illumina to sell cancer-test maker Grail after latest antitrust ruling
Market Watch - 17 Dec 2023 23:55
Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive.
Share this Article
Recommended